Frequently Asked Questions
Frequently Asked Questions
HUVY, its operation, and its use: answers to questions from patients, healthcare professionals, and preventive care organizations.
Cannot find your answer?
Our team is here to answer your questions, whether you are a patient, a healthcare professional, or a preventive healthcare organization.
Patients
HUVY is a medical device intended to assist in the assessment of melanoma risk, used by primary care professionals such as your physician or pharmacist.
Based on an image of the lesion captured with a dermatoscope, HUVY provides a melanoma risk score. Any decision regarding subsequent clinical management remains at the discretion of the healthcare professional.
The analysis is performed at a physician's office or pharmacy equipped with HUVY. No prescription is required.
Is your healthcare professional not yet equipped? Let us know using the form on the Patients page.
You are seated in a private area. The healthcare professional captures an image of the lesion using a dermatoscope; the HUVY AI then analyzes the image and provides a melanoma risk score within 15 seconds. The consultation takes an average of 10 minutes. Based on the melanoma risk score, the healthcare professional will guide you through the next steps of your care pathway.
The fee is set at the sole discretion of the healthcare professional. HUVY recommends a fee of €20 to €25 per consultation. To date, this analysis is not covered by national health insurance. Some complementary health insurers may cover it, typically under their cancer prevention packages, upon presentation of the invoice provided by your healthcare professional.
No. HUVY provides a melanoma risk score to support the healthcare professional's decision. The diagnosis is made by a physician.
Regardless of the melanoma risk score, you will leave with a report. If a dermatological evaluation is deemed necessary, a referral letter will be provided to you to share with your primary care physician or dermatologist, depending on the care pathway in your area.
Please have a method of payment ready (cash or credit/debit card) and a valid email address to receive your report.
Healthcare Professionals
To primary care healthcare professionals: pharmacists, general practitioners, nurses, and other healthcare professionals, as well as multidisciplinary health centers. Each profession has a tailored offering, presented on the Healthcare Professionals page.
The subscription includes:
- Access to the HUVY platform on smartphone, tablet, and computer;
- A set number of analyses defined by your plan;
- The 4 mandatory training modules;
- A communication toolkit to launch the service;
- Dedicated support from the HUVY team.
The commitment term is 12 months, with monthly credit card payments. The dermatoscope is not included; we can recommend compatible models.
- Subscribe to the plan tailored to your profession
- Equip yourself with a dermatoscope
- Activate your account using the "Welcome to HUVY" email
- Complete the 4 training modules, required prior to your first analysis
- Set up the provided communication materials
Our team remains at your disposal to support you through every step.
All CE-marked dermatoscopes are compatible, including those already installed in teleconsultation booths.
As a general rule, patients are referred to their primary care physician, who then determines whether a dermatological assessment is warranted. HUVY adheres to the guidelines of the French Society of Dermatology (SFD) and integrates into local healthcare pathways. Following analysis, you can generate a referral letter directly from your account, complete with the clinical image and the melanoma risk score. The physician may also request a remote specialist opinion (tele-expertise) from a dermatologist via Omnidoc.
HUVY is a Class IIb, CE-marked medical device compliant with European Regulation (EU) 2017/745. Consequently, your liability is defined and compliant with health authority requirements.
You have an obligation of means, not of results: perform the analysis using a medical device certified at the appropriate level (CE Class IIb) and follow the steps outlined on the platform. The device's performance remains the responsibility of the manufacturer.
Collective prevention
Occupational health services, enterprises, territorial professional healthcare communities (CPTS), mutual insurers and insurance companies, local authorities: HUVY assists you in deploying prevention initiatives for your target audiences.
Melanoma risk assessment days held on-site at your premises or during your events, training for healthcare professionals within your facility or network, and comprehensive deployment support provided by our team.
The device is available upon request for a quote, based on the size of your facility, your target audiences, and the selected format.
Activity reporting based on aggregated data to measure participation and the impact of your initiatives.
The Device and Your Data
Yes. HUVY has been a CE-certified Class IIb medical device since February 2025, in compliance with European Regulation (EU) 2017/745. This certification requires an audit by an independent notified body and an annual conformity assessment.
96% sensitivity and 72% specificity, established across more than 3,000 lesions in three pre-market studies and subsequently confirmed by a post-market surveillance study involving 1,500 cases. These findings were published in JEADV Clinical Practice.
Yes. Images and data are hosted in France on HDS-certified (Health Data Hosting) servers, in full compliance with the GDPR.
The development of HUVY was overseen in 2024 and 2025 by an independent scientific committee, bringing together leading academic dermatologists.
Do you have another question?
Contact us: our team will get back to you, whether you are a patient, healthcare professional, or preventive care organization.
